Jump to content
April 2024 Challenge

R1R2

Members
 View Profile  See their activity

  • Posts

    556

  • Joined

  • Last visited

  • Days Won

    22

  • Country

    United States

 Content Type 

Everything posted by R1R2

  1. R1R2
    I was being facetious. I haven't seen a bleeding time in decades.
  2. R1R2
    What's a bleeding time?
  3. R1R2
    Not all major ABO incompatibility transfusions result in death. I recently read somewhere that a few percentage (can't remember the exact number) up to 30% are fatal. In my career I have seen one not fatal and one fatal,.
  4. R1R2
    I only do one comparison semiannually.
  5. R1R2
    yes, yes, yes, yes!
  6. R1R2
    I think it develops with experience. Our older peers said the same thing about us.
  7. R1R2
    so, is the employee still around?
  8. R1R2
    PERHAPS weak D was included because a positive weak D would alert you to a possible false positive fetal screen.
  9. R1R2
    "CFR 606.100(c) "All records pertinent to a lot or unit were not reviewed before the release or distribution of a lot or unit of final product". The inspector asserts that testing review must be performed prior to releasing products and since supervisory review is typically performed each morning, any products that were released throughout the day (or night) would not have had their associated testing reviewed prior to release. " I don't think any of our responses helped you with this FDA observation, did they?
  10. R1R2
    In my house, the cake would not make it to the next day.
  11. R1R2
    Agree with TreeMoss. I would check your FDA paperwork and make sure it is correct. I took over a transfusion service and they had registered even though they did not need to register. I changed that right quick.
  12. R1R2
    I know that FDA can visit any hospital but curious as to why they visited you if you only thaw plasma? Do you have an LIS or do you record results on logs?
  13. R1R2
    Was this in reference to daily QC perhaps?
  14. R1R2
    I would think that the freshest irradiated or unirradiated unit you have on hand would be suitable for a baby in a true emergency. A full unit could be issued and tranfusionist would use what they needed and discard. This plan should be discussed with all involved before it happens to make sure everyone is OK with this. Perhaps a procedure should be written as well.
  15. R1R2
    we purchase pooled cryo from the blood center. no more pooling
  16. R1R2
    There is no requirement that the info is read back to a person at time of issue.
  17. R1R2
    I like the way your new supervisor has you performing antibody ID and panels. Why would you continue running full panels after the first if you can start narrowing down the specificity after the first panel and run selected cells? For example, if you suspect the patient has anti e, why run any more e+ cells? Not sure I agree with the DAT if auto control is negative. I think many transfusion services do not do this but I imagine that reference labs do. There may be times when running a DAT is advised when autocontrol is negative but running DATs routinely when an auto control is negative will just take you down a path that will delay blood transfusion IMO
  18. R1R2
    IN the US, a titer is not usually done before transfusing a non group O baby with group O pack cell aliquots. I have only seen one case in which passive anti A was found in a neonate after transfusion of group O pack cell aliquots. There was not patient harm.
  19. R1R2
    No need to take a separate internal temperature providing your digital temp is accurate. You will need to validate your digital readout to NIST and then you are all set.
  20. R1R2
    I have never seen an "extreme case" of antigen blocking resulting in a negative test and I would think that the baby would have a lot of other serological issues that might alert you that this might be going on. Our facility allows newborn weak D testing when the DAT is positive and most of the time the weak D is negative. If you have staff that can understand this process then it might be a good idea.
  21. R1R2
    No you can't but you can run select cells instead of a full panel. You may even skip the antibody screen and go right to the select cell panel.
  22. R1R2
    Your reverse cells are probably Rh- and may react with anti c. Using gel will only enhance this reaction since the plasma/cells are in contact for 10+ minutes or more especially if using automation. You probably ran your reverse tube without delay so you did not pick up the anti c. If you incubated your tube reverse B cell at 37 you would probably pick up some reactivity. I have seen this many times especially with anti c.
  23. R1R2
    Our system dropped them 5+ years ago. We were and continue doing 2 samples for ABO Rh and electronic crossmatch. Our process for positive patient ID is 3 identifiers and labeling in the presence of the patient.
  24. R1R2
    Yes, I have seen this many times since using the Provue. I think your theory about where the probe samples and where a human samples is correct.
  25. R1R2
    Which one will you report in the EMR? A good response to your interviewer would be that you would consult the policy.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.